Antibacterial activity of synthetic pyrido[2,3-d]pyrimidines armed with nitrile groups: POM analysis and identification of pharmacophore sites of nitriles as important pro-drugs
- 16 August 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 42 (19) , 15610-15617
Abstract
A clean and simple one-pot multi-component methodology was developed for the preparation of 7-amino-2,4-dioxo-5-aryl-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitriles via the reaction of 6-amino uracil, aromatic aldehydes and malononitrile using triethylamine (TEA) base as a catalyst in aqueous ethanol medium at NTP. The reaction protocol has assorted advantages viz.; mild reaction conditions, short reaction time, environmentally friendly procedure, low cost chemicals, and easy isolation of derivatives with excellent yields of bioactive products (85–95%). All the synthesised pyrido[2,3-d]pyrimidines bearing nitrile groups (4a–4h) showed comparatively good in vitro antibacterial activities against Staphylococcus and Bacillus cereus (Gram-positive bacteria) and P. merabitis and S. maresens (Gram-negative bacteria). Nevertheless, compound 4h exhibited the highest antibacterial activity and had an excellent % inhibition as compared to standard streptomycin. Overall, compound 4h had enhanced antibacterial activity compared to its positional isomers compound 4f and compound 4g. This increase in bioactivity going from 4f (R = 4-nitro) to 4h (R = 2-nitro) is attributed to the hydrolysis of the CN to an amide which restores the vital intramolecular interaction between the ortho-nitro-phenyl and amide linkages (ONOδ−⋯Hδ+N) and offers a crucial template for antibacterial NH, O-pharmacophore sites. The synthesized compound 4h was tested to verify that it had fewer side effects than the standard/streptomycin. But, its possible inclusion in selective fungal/viral media viz. HIV or Hepatitis B/C is a subject of further research. This multi-component synthetic protocol uses cheap ingredients like Et3N catalyst and ethanol as the green solvent.Keywords
This publication has 32 references indexed in Scilit:
- Novel pyrimidine derivatives by sonication and traditional thermal methodsGreen Chemistry Letters and Reviews, 2010
- Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse TranscriptaseJournal of Medicinal Chemistry, 2008
- Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivativeBioorganic & Medicinal Chemistry Letters, 2006
- Pyrazolo[3,4-c]pyridazines as Novel and Selective Inhibitors of Cyclin-Dependent KinasesJournal of Medicinal Chemistry, 2005
- KF‐Alumina Catalyzed One‐Pot Synthesis of Pyrido[2,3‐d]Pyrimidine DerivativesSynthetic Communications, 2004
- Synthesis and Evaluation of Some Pyrazolo[3,4-d]pyridazinones and Analogues as PDE 5 Inhibitors Potentially Useful as Peripheral Vasodilator AgentsJournal of Enzyme Inhibition and Medicinal Chemistry, 2002
- Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorJournal of Medicinal Chemistry, 1995
- Synthesis and Antimicrobial Activity of 6,7-Annulated Pyrid0[2,3-d]pyrimidineJournal of Pharmaceutical Sciences, 1995
- Enantioselective hydrolysis of racemic naproxen nitrile and naproxen amide to S-naproxen by new bacterial isolatesJournal of Biotechnology, 1994
- Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivativesJournal of Medicinal Chemistry, 1981